LONDON, 7 October 2026 — Kantesti Ltd launched Plague Check in London on 7 October 2026. The AI-assisted educational decision-support tool is rolling out in its clinic dashboard to help doctors consider possible plague early and decide whether action is needed the same hour.

Time-sensitive decision support in the clinic dashboard

The tool is rolling out now in the Kantesti clinic dashboard for healthcare professionals. It is included for every premium report customer and every clinic account, with no credits or add-on charge. It brings exposure questions, blood test information and guideline-based next steps together in minutes for a doctor to evaluate.

Plague is a rare, treatable bacterial illness caused by Yersinia pestis, not a virus. Cases still appear each year in DR Congo, Madagascar, Mongolia and the United States. Authorities are also watching a suspected, unconfirmed laboratory-linked case in Siberia.

Early treatment matters, but a routine blood test cannot identify plague. Antibiotics started early save most patients, while untreated pneumonic plague is almost always fatal. Anyone who develops fever after a possible plague exposure should seek urgent medical care.

“With plague, the danger is not the treatment. It is the hours lost before anyone thinks of it. Plague Check brings the right questions, the patient's own blood results and the WHO and CDC steps onto one screen, in minutes.”

Clinicians combine exposure history with up to five blood reports

A clinician starts by selecting up to five interpreted blood test reports, which the tool reads together from oldest to newest. Kantesti AI reads each value against the laboratory's own reference ranges. The clinician then answers questions about travel, animals, contacts and laboratory work, alongside fever, painful lymph nodes, bloody cough and signs of sepsis.

The output is available in minutes and gives a suspicion score, a triage tier ranging from "exposure only" to "act now", and a WHO case stage. The stages shown in the source document are not a case, suspected, presumptive and confirmed. The tool's output does not itself establish laboratory confirmation.

A separate severity view draws on vital signs and blood test information to show sepsis, clotting, kidney and liver signals. Severity is kept apart from suspicion so clinicians can review indications of how ill a patient is separately from concern about plague. Routine blood results cannot confirm or exclude plague.

The report sets out confirmation and public-health steps

The next-steps view covers confirmatory tests, isolation and public-health notification, alongside WHO and CDC treatment guidance for the doctor to evaluate. The stated references are WHO 2021 plague guidance and CDC MMWR 2021. Treatment decisions, including doses, remain with the treating doctor.

The report explicitly states that routine blood tests cannot confirm or exclude plague and names tests that can support laboratory confirmation. A labelled illustrative example mentions blood cultures, a bubo aspirate, an F1 rapid test and PCR. Its suspicion score of 78 of 100 and qSOFA 2 / 3 are sample display values, not a reported patient result or evidence of the tool's performance.

Clinicians can print and share the resulting report. White-label clinics receive their own logo and details on the printable version. Reports can be written in a chosen language from 101 available languages, while the interface follows the dashboard in 39 languages.

Case-definition rules cannot be lowered by the AI

A rule engine based on WHO and CDC case definitions sets a floor for each assessment. The AI can raise concern but cannot lower it. A doctor must still evaluate the patient, arrange appropriate tests and make clinical decisions.

Plague Check provides AI-assisted educational decision support for healthcare professionals, not a diagnosis. It is not a medical device and does not replace clinical judgement or laboratory confirmation. Findings should be confirmed by a doctor.

The WHO plague fact sheet cited in the source describes spread through flea bites and infected animals, and through droplets in pneumonic plague. It gives an incubation period of about 1 to 7 days and describes treatment with common antibiotics, best started early. These details provide context for the exposure questions and the need for timely medical care.

Assessments remain in the clinic account

Assessments stay in the clinic's account and are deleted with the associated patient or blood test. Access is through the Kantesti clinic dashboard; the assessment is designed for healthcare professionals rather than as a stand-alone patient service.

Julian Emirhan Bulut, Founder and Director of Kantesti Ltd, said the tool brings the questions, the patient's blood results and WHO and CDC steps into one view to help address time lost before plague is considered. The treating doctor remains responsible for decisions about laboratory confirmation and care.

Kantesti Ltd is a UK-registered health technology company that turns laboratory results into AI-assisted explanations for more than 2 million users. Its platform interprets blood tests uploaded as PDFs or photos in more than 100 languages. For individuals and clinics, it also offers biological blood age, a body map, comparison and trend analysis, nutrition plans, DNA-based health reports and Kantesti Voice.

Source document

Frequently asked questions

Who can access Plague Check, and what does it cost?

Plague Check is rolling out in the Kantesti clinic dashboard for healthcare professionals. It is free for every Kantesti premium report customer and every clinic account, with no credits or add-on charge. Access is through the clinic dashboard, not a stand-alone patient service.

What information does a clinician enter?

A clinician selects up to five interpreted blood test reports, which the tool reads from oldest to newest against each laboratory's reference ranges. The clinician also answers questions about travel, animals, contacts and laboratory work, and about fever, painful lymph nodes, bloody cough and signs of sepsis. The output is available in minutes.

Can the tool or a routine blood test confirm plague?

No. Plague Check does not diagnose plague or replace clinical judgement and laboratory confirmation. Its report says routine blood tests can help show how ill a patient is but cannot confirm or exclude plague. It names tests for confirmation and presents next steps for the treating doctor to assess.

What safeguards govern its output and patient information?

A rule engine based on WHO and CDC case definitions sets a floor for each assessment: the AI can raise concern but cannot lower it. Suspicion and severity appear separately, and treatment doses remain the treating doctor's responsibility. Assessments stay in the clinic's account and are deleted with the associated patient or blood test.

###

Notes to editors

1. Plague Check produces printable reports in 101 languages; its interface follows the Kantesti dashboard in 39 languages.
2. The assessment includes a suspicion score, a triage tier, a WHO case stage and a separate severity view. A score of 78 of 100 shown in the PDF is expressly illustrative.
3. The PDF cites WHO 2021 plague guidance and CDC MMWR 2021 for next steps. It cites the WHO plague fact sheet for background on transmission, incubation and treatment.
4. Kantesti Ltd is registered in England and Wales under company number 17090423. The PDF lists its address as 4 Raven Road, Unit 1c3-1100, London E18 1HB, United Kingdom.
5. Media contact: [email protected]. Website: www.kantesti.net.

About Kantesti

Kantesti Ltd is a UK-registered health technology company (Companies House No. 17090423) that turns laboratory results into clear, AI-assisted explanations for more than 2 million users. Its platform interprets blood tests uploaded as PDFs or photos in more than 100 languages and adds tools such as a biological blood age, a body map, comparison and trend analysis, nutrition plans, DNA-based health reports and Kantesti Voice, for individuals and clinics.

Kantesti Ltd · Companies House No. 17090423 · 4 Raven Road, Unit 1c3-1100, London E18 1HB, United Kingdom

Media contact

Kantesti Ltd — Press Office
[email protected]
+44 7508 364740
www.kantesti.net

Media assets

• 1536×1024 · ↓
• 1536×1024 · ↓
• 1536×1024 · ↓
• 1536×1024 · ↓
• 1536×1024 · ↓
• 1536×1024 · ↓